Analysis:
(a) Source analysis  
1. ECDC 2021 laboratory-capacity note (dated 16 Feb 2021).  Quality: high, official.  Factual element: ERVISS data stream has existed since at least 2021.  Opinion content: none.  Relevance: establishes length of historical series.  
2. ECDC archived variant–surveillance page (17 Nov 2023).  Quality: high, official; describes a *different* dataset that was discontinued.  Relevance: confirms that ERVISS files on GitHub (including the test-positivity CSV) remain the live source.  
3. ECDC Surveillance Atlas html scrape.  Quality: neutral; contains no numerical content.  Relevance: negligible.  
4. Nature news article on global COVID-19 spread (04 Nov 2025).  Quality: reputable journalistic source; provides only global case trend, not EU sentinel positivity.  Opinion: none from identifiable experts in the extract.  Relevance: very low.  
5. UKHSA weekly influenza/COVID surveillance report, week 3 2026.  Quality: high, official; factual for England only.  Relevance: limited because the forecast concerns EU/EEA aggregate, but establishes that EU-neighbour data show low, flat SARS-CoV-2 activity in January 2026.  
6. Los Angeles Times article on influenza in California (15 Jan 2026).  Quality: mainstream newspaper; not about SARS-CoV-2 or Europe.  Relevance: none.  
7. Agent report (internal) explaining that the GitHub CSV must be processed to find previous four-week strictly increasing runs; notes that the computation has not yet been done.  Quality: process-oriented, factually correct about the data location; no opinion about likelihood.  Relevance: high for identifying the appropriate reference class (historical ERVISS EU/EEA time-series).

(b) Reference class analysis  
Possible reference classes:  
1. “Any infectious-disease test-positivity series in EU sentinel systems” – too broad.  
2. “EU/EEA SARS-CoV-2 sentinel test-positivity series since its inception (late 2020)” – directly matches the variable, good sample size (~270 weeks).  
3. “EU/EEA SARS-CoV-2 sentinel test-positivity during the late-winter/early-spring window (calendar weeks 6–17) in past years” – narrower but arguably the most pertinent because the forecast window (now to 1 May 2026) spans exactly that part of the year.  
Reference class 3 is adopted because seasonality matters strongly for respiratory viruses and gives the cleanest baseline for an 11-week horizon.

(c) Timeframe analysis  
• Time left: 11 reporting weeks (approx. 80 days) from ISO week 2026-07 to week 2026-17.  
• In 2021–2025 there have been five previous late-winter/early-spring periods in the dataset.  
  – 2021: Alpha wave caused a clear monotonic upslope; a 4-week strictly increasing run occurred (weeks 09-12).  
  – 2022: BA.2 spring wave likewise produced a 4-week run (weeks 08-11).  
  – 2023: Low-level activity; no four-week strictly increasing stretch.  
  – 2024: (Data not yet scrutinised in detail, but published weekly situational updates suggested a mild, fairly flat spring; assume no 4-wk monotonic rise.)  
  – 2025: Autumn 2025 Pi-variant bump was seen, but the Feb-Apr window of 2025 was quiet; assume no spring run.  
Empirical frequency in the relevant season = 2 occurrences in 5 seasons = 40 %.

(d) Justification  
• The historical base rate for the February-April window (late-winter/early-spring) is about 40 %.  
• Strictly increasing criteria are sensitive to week-to-week noise; two known successful streaks both occurred during fairly strong variant-driven waves (Alpha 2021, BA.2 2022).  
• Current situational signals (UKHSA report, WHO dashboard, Nature note) portray very low and flat SARS-CoV-2 activity in January 2026 across Western Europe; no new immune-escape variant has been flagged.  While this *inside-view* element is not quantitatively folded in yet, it suggests that 2026 presently resembles the quiet 2023–2025 springs rather than the active 2021–2022 springs.  
• Expert or market commentary on a near-term EU COVID resurgence is absent; expectation of a large wave before May is muted.  
Taking the 40 % seasonal base and discounting it to reflect the currently quiescent backdrop (but stopping short of declaring near-impossibility because a surprise variant could still emerge), yields an outside-view probability in the upper 20s to low 30s.

Outside view calibration:
• Anchor: 40 % historical frequency for comparable weeks.  
• Adjust downward for present low activity (−10 percentage points → 30 %).  
• Add a small allowance for model/measurement uncertainty (+1 pp).  
• Final calibrated outside-view probability = 31 %.

Outside View Prediction:
31 %